Archive

This case explores the challenges facing a new Chief Human Resources Officer as she evaluates health insurance benefits at a financial services company with 100,000 employees. Bank4 faces increasing costs while its employees see rising out-of-pocket…

This case is located within the multinational pharmaceutical company Novartis, as key managers decide what kind of monitoring and evaluation to implement for one of its social business programs, Novartis Access. This new program will expand the company’s…

Governor A was preparing for a forum on health sector reforms to be held the next week. The Governor wanted to make health reform one of her flagship programs during the upcoming local elections, and, in particular, wanted to consider ways of lowering…

Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company’s drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on…

In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in…